Publications & Podcasts August 27, 2020 Alerts and Newsletters News Flash: HHS Issues Statement Removing Premarket Review Requirements for Laboratory Developed Tests (“LDTs”), Including COVID-19 LDTs June 18, 2020 Alerts and Newsletters FDA Issues Guidance on IRB Review of Non-Emergency Individual Patient Expanded Access Requests for Investigational Drugs and Biological Products to Treat COVID-19 June 12, 2020 Alerts and Newsletters FDA Announces New Updates to its Guidance on Conducting Clinical Trials During COVID-19 and Notes Availability of its COVID MyStudies App March 19, 2020 Alerts and Newsletters COVID-19 Expanded Access Template January 15, 2020 Alerts and Newsletters More Proposed Changes to CCPA Geared to Health Care and Life Sciences Industries October 25, 2019 Alerts and Newsletters Proposed Regulations Under the CCPA Provide Some Clarity, But Questions Remain July 30, 2019 Alerts and Newsletters Massachusetts Budget Update: Commonwealth Now Waiting on Governor Baker February 19, 2019 Alerts and Newsletters OIG Proposes Revisions to Anti-Kickback Safe Harbor Regulations Affecting Prescription Drug Rebates February 11, 2019 Alerts and Newsletters Governor Baker’s 2020 Budget Would Allow MassHealth Authority to Negotiate Supplemental Rebates with Pharmaceutical Companies January 10, 2019 Alerts and Newsletters One Month Left to Submit Comments on HIPAA Request for Information January 10, 2019 Alerts and Newsletters Is Cybersecurity on Your 2019 Work Plan? October 31, 2018 Alerts and Newsletters Tag, You’re It: FDA Issues Guidance Ahead of Revisions to its Human Subjects Protection Regulations
August 27, 2020 Alerts and Newsletters News Flash: HHS Issues Statement Removing Premarket Review Requirements for Laboratory Developed Tests (“LDTs”), Including COVID-19 LDTs
June 18, 2020 Alerts and Newsletters FDA Issues Guidance on IRB Review of Non-Emergency Individual Patient Expanded Access Requests for Investigational Drugs and Biological Products to Treat COVID-19
June 12, 2020 Alerts and Newsletters FDA Announces New Updates to its Guidance on Conducting Clinical Trials During COVID-19 and Notes Availability of its COVID MyStudies App
January 15, 2020 Alerts and Newsletters More Proposed Changes to CCPA Geared to Health Care and Life Sciences Industries
October 25, 2019 Alerts and Newsletters Proposed Regulations Under the CCPA Provide Some Clarity, But Questions Remain
July 30, 2019 Alerts and Newsletters Massachusetts Budget Update: Commonwealth Now Waiting on Governor Baker
February 19, 2019 Alerts and Newsletters OIG Proposes Revisions to Anti-Kickback Safe Harbor Regulations Affecting Prescription Drug Rebates
February 11, 2019 Alerts and Newsletters Governor Baker’s 2020 Budget Would Allow MassHealth Authority to Negotiate Supplemental Rebates with Pharmaceutical Companies
January 10, 2019 Alerts and Newsletters One Month Left to Submit Comments on HIPAA Request for Information
October 31, 2018 Alerts and Newsletters Tag, You’re It: FDA Issues Guidance Ahead of Revisions to its Human Subjects Protection Regulations